TEIHX
Price
$43.16
Change
+$0.21 (+0.49%)
Updated
Jun 27 closing price
Net Assets
52.53B
VTSMX
Price
$147.61
Change
+$0.70 (+0.48%)
Updated
Jun 27 closing price
Net Assets
1.82T
Interact to see
Advertisement

TEIHX vs VTSMX

Header iconTEIHX vs VTSMX Comparison
Open Charts TEIHX vs VTSMXBanner chart's image
Nuveen Equity Index I
Price$43.16
Change+$0.21 (+0.49%)
VolumeN/A
Net Assets52.53B
Vanguard Total Stock Mkt Idx I
Price$147.61
Change+$0.70 (+0.48%)
VolumeN/A
Net Assets1.82T
TEIHX vs VTSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TEIHX vs. VTSMX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TEIHX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.82T vs. TEIHX (52.5B). VTSMX (1.18) and TEIHX (1.17) have matching dividends . TEIHX was incepted earlier than VTSMX: TEIHX (10 years) vs VTSMX (33 years). TEIHX (0.15) is less costly to investors than VTSMX (0.14). TEIHX is a more actively managed with annual turnover of: 3.00 vs. VTSMX (2.00). VTSMX has a lower initial minimum investment than TEIHX: VTSMX (3000) vs TEIHX (100000). TEIHX annual gain was more profitable for investors over the last year : 13.85 vs. VTSMX (12.74). TEIHX return over 5 years is better than : 107.93 vs. VTSMX (100.35).
TEIHXVTSMXTEIHX / VTSMX
Total Expense Ratio0.150.14107%
Annual Report Gross Expense Ratio0.150.14107%
Fund Existence10 years33 years-
Gain YTD5.1664.718109%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets52.5B1.82T3%
Annual Yield % from dividends1.171.1899%
Returns for 1 year13.8512.74109%
Returns for 3 years62.4159.49105%
Returns for 5 years107.93100.35108%
Returns for 10 yearsN/A193.84-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSLS2.430.05
+2.10%
ReShape Lifesciences Inc.
DVA141.670.58
+0.41%
DaVita
ARWR16.080.01
+0.06%
Arrowhead Pharmaceuticals
CCRD28.18-0.65
-2.25%
CoreCard Corp
ZVRA9.00-0.28
-3.02%
Zevra Therapeutics